Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

Sep 14, 2020
|
staff reporter

NEW YORK ─ GenMark Diagnostics said on Monday that it has received the CE mark for the ePlex Respiratory Pathogen Panel 2 (RP2), enabling its use in Europe and other regions that accept the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Technical, But Key Meeting

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

Spinning an FDA "Cocoon"

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Gene for When to Go

Researchers have identified a gene involved in how people determine when to urinate.

Genome Research Papers on Chromatin Accessibility, Malaria Mosquitoes, Bacterial Pan-Genome Method

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.

Oct
22
Featured Webinar

Adoption of Broad NGS Profiling for HRR Deficiency: Looking Beyond BRCA, SNPs, and Indels

Sponsored by
Sophia Genetics

This webinar will share the Lorraine Cancer Institute's experience in implementing a novel targeted solution to accurately assess homologous recombination repair (HRR) deficiency by analyzing a series of genes, beyond BRCA, and calling multiple types of variants, including copy number variants (CNVs).

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

What's Popular?

In Molecular Diagnostics

  1. Centogene Increases Full-Year Revenue Guidance; CEO Resigns

  2. Thermo Fisher Scientific Q3 Revenues Soar 36 Percent

  3. CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

  4. Abbott Q3 Diagnostics Revenues Increase 38 Percent

  5. Interdisciplinary NIST Team Claims qPCR Improvements Using Unusual Math Tweaks

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.